Rhone-Poulenc Rorer, Inc. Press Releases
-
- 12/12/95 – Rilutek® (riluzole) approved by U.S. Food and Drug Administration
for treatment of Lou Gehrig’s Disease. - 1/10/96 – Rilutek® (riluzole) now available by prescription for people with Lou Gehrig’s Disease.
- Orbis Radio News Special Report – FDA approval of the first treatment for ALS (Lou Gehrig’s Disease).